• FirefoxUpgrade to the new Firefox »
  •  Dow Up0.13% Nasdaq Up0.70%

    Threshold Pharmaceuticals Inc. (THLD)

    -NasdaqCM
    3.04 Up 0.11(3.75%) Dec 26, 4:00PM EST
    Add to Portfolio
    Income StatementGet Income Statement for:
    View: Annual Data | Quarterly DataAll numbers in thousands
    Period EndingDec 31, 2013Dec 31, 2012Dec 31, 2011
    Total Revenue 12,495   5,867   62  
    Cost of Revenue -   -   -  
    Gross Profit 12,495   5,867   62  
    Operating Expenses
    Research Development29,334  18,786  24,388  
    Selling General and Administrative9,185  7,080  5,710  
    Non Recurring -   -   -  
    Others -   -   -  
    Total Operating Expenses -   -   -  
    Operating Income or Loss (26,024) (19,999) (30,036)
    Income from Continuing Operations
    Total Other Income/Expenses Net(2,189)(51,136)4,383  
    Earnings Before Interest And Taxes(28,213)(71,135)(25,653)
    Interest Expense -   -   -  
    Income Before Tax(28,213)(71,135)(25,653)
    Income Tax Expense202   -   -  
    Minority Interest -   -   -  
    Net Income From Continuing Ops(28,415)(71,135)(25,653)
    Non-recurring Events
    Discontinued Operations -   -   -  
    Extraordinary Items -   -   -  
    Effect Of Accounting Changes -   -   -  
    Other Items -   -   -  
    Net Income (28,415) (71,135) (25,653)
    Preferred Stock And Other Adjustments -   -   -  
    Net Income Applicable To Common Shares (28,415) (71,135) (25,653)

    Sign Up for a Free Trial to EDGAR Online Premium!
    Get the critical business and financial information you need for more than 15,000 U.S. public companies.
    Sign Up Now - Learn More

    Currency in USD.